Birdwatch Archive

Birdwatch Note

2023-12-04 04:18:26 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

この話はファイザーワクチンの臨床試験の有効性は相対リスクだと95%減少(プラセボ162人→ワクチン8人）だが絶対リスクだと解析者約18000人の参加者中154人(0.85%)しか減っていないという話ですが↓ https://www.reuters.com/article/factcheck-thelancet-riskreduction/fact-check-why-relative-risk-reduction-not-absolute-risk-reduction-is-most-often-used-in-calculating-vaccine-efficacy-idUSL2N2NK1XA/ プラセボも162人しか発症してないというのは「流行が下火の20年秋の試験中の中央値2か月間」の話で↓ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115787/ 米国なら接種完了後に日常に戻る中、接種があっても新型コロナには3分の1の現役世代が21年秋には毒性の高い株での感染抗体を保持しており↓ https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm#F1_down 接種してもしなくても99%の人の帰結には差がない様な示唆こそ米国では誤謬だった事は言うまでもありません

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1731516234976645603

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1731528363041542619
  • noteId - 1731528363041542619
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1701663506647
  • tweetId - 1731516234976645603
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • この話はファイザーワクチンの臨床試験の有効性は相対リスクだと95%減少(プラセボ162人→ワクチン8人）だが絶対リスクだと解析者約18000人の参加者中154人(0.85%)しか減っていないという話ですが↓ https://www.reuters.com/article/factcheck-thelancet-riskreduction/fact-check-why-relative-risk-reduction-not-absolute-risk-reduction-is-most-often-used-in-calculating-vaccine-efficacy-idUSL2N2NK1XA/ プラセボも162人しか発症してないというのは「流行が下火の20年秋の試験中の中央値2か月間」の話で↓ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115787/ 米国なら接種完了後に日常に戻る中、接種があっても新型コロナには3分の1の現役世代が21年秋には毒性の高い株での感染抗体を保持しており↓ https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm#F1_down 接種してもしなくても99%の人の帰結には差がない様な示唆こそ米国では誤謬だった事は言うまでもありません

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-12-04 04:18:26 UTC
(1701663506647)		 1969-12-31 23:59:59 UTC
(-1)		 2023-12-05 03:33:02 UTC
(1701747182239)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-12-04 17:41:02 -0600 Rating Details
2023-12-04 15:00:13 -0600 Rating Details
2023-12-04 09:40:13 -0600 Rating Details
2023-12-04 07:42:39 -0600 Rating Details
2023-12-04 06:55:44 -0600 Rating Details
2023-12-04 06:12:41 -0600 Rating Details
2023-12-04 04:05:28 -0600 Rating Details
2023-12-04 03:50:46 -0600 Rating Details
2023-12-04 02:20:31 -0600 Rating Details
2023-12-04 02:05:53 -0600 Rating Details
2023-12-04 01:52:42 -0600 Rating Details
2023-12-04 01:42:50 -0600 Rating Details
2023-12-04 01:30:32 -0600 Rating Details
2023-12-04 01:29:54 -0600 Rating Details
2023-12-04 01:25:05 -0600 Rating Details
2023-12-04 01:18:26 -0600 Rating Details
2023-12-04 01:02:18 -0600 Rating Details
2023-12-04 00:03:23 -0600 Rating Details
2023-12-03 23:57:54 -0600 Rating Details
2023-12-03 23:38:03 -0600 Rating Details
2023-12-03 22:41:12 -0600 Rating Details
2023-12-03 22:39:33 -0600 Rating Details
2023-12-03 22:30:15 -0600 Rating Details
2023-12-04 14:28:41 -0600 Rating Details
2023-12-04 08:25:37 -0600 Rating Details
2023-12-03 22:38:26 -0600 Rating Details
2023-12-03 22:38:25 -0600 Rating Details